Anthem Biosciences Ltd
NSE:ANTHEM
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
592.4
864.5
|
| Price Target |
|
We'll email you a reminder when the closing price reaches INR.
Choose the stock you wish to monitor with a price alert.
This alert will be permanently deleted.
Operating Margin
Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.
Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.
Peer Comparison
| Country | Company | Market Cap |
Operating Margin |
||
|---|---|---|---|---|---|
| IN |
A
|
Anthem Biosciences Ltd
NSE:ANTHEM
|
332.7B INR |
Loading...
|
|
| US |
P
|
PerkinElmer Inc
LSE:0KHE
|
1.3T USD |
Loading...
|
|
| US |
|
Thermo Fisher Scientific Inc
NYSE:TMO
|
236.2B USD |
Loading...
|
|
| US |
|
Danaher Corp
NYSE:DHR
|
166.4B USD |
Loading...
|
|
| KR |
|
Samsung Biologics Co Ltd
KRX:207940
|
82.9T KRW |
Loading...
|
|
| CH |
|
Lonza Group AG
SIX:LONN
|
38.5B CHF |
Loading...
|
|
| US |
|
IQVIA Holdings Inc
NYSE:IQV
|
41.4B USD |
Loading...
|
|
| CN |
|
WuXi AppTec Co Ltd
SSE:603259
|
274.7B CNY |
Loading...
|
|
| US |
|
Agilent Technologies Inc
NYSE:A
|
38.7B USD |
Loading...
|
|
| US |
|
Mettler-Toledo International Inc
NYSE:MTD
|
29.3B USD |
Loading...
|
|
| FR |
|
Sartorius Stedim Biotech SA
PAR:DIM
|
19.9B EUR |
Loading...
|
Market Distribution
| Min | -153 833.3% |
| 30th Percentile | 2.7% |
| Median | 7.3% |
| 70th Percentile | 13.2% |
| Max | 9 977% |
Other Profitability Ratios
Anthem Biosciences Ltd
Glance View
Anthem BioSciences Ltd. engages in contract research, development and manufacturing, and organization with fully integrated operations spanning across drug discovery, development and manufacturing. The company is headquartered in Bangalore, Karnataka and currently employs 2,062 full-time employees. The company went IPO on 2025-07-21. The firm helps new and established biotech’s and big pharma, develop, optimize and test proteins, monoclonal antibodies, peptides, large molecules, small molecules, toxins and much more. In addition to product research and development, it helps test drugs for safety, efficacy (in vitro and in vivo), pre-clinical animal studies in a GLP facility, clone development, antibody drug conjugates, research and development and manufacture of highly potent compounds, flow chemistry-based production and large-scale commercial product manufacture. Its product line includes human nutrition, animal health, and industrial products. Under human nutrition, it offers active pharmaceutical ingredients, dietary supplements, probiotics, and enzymes, among others.
See Also
Operating Margin is calculated by dividing the Operating Income by the Revenue.
The current Operating Margin for Anthem Biosciences Ltd is 31.6%, which is below its 3-year median of 32%.
Over the last 2 years, Anthem Biosciences Ltd’s Operating Margin has decreased from 34.6% to 31.6%. During this period, it reached a low of 29.8% on Mar 31, 2024 and a high of 34.6% on Mar 3, 2023.